Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Mobia Medical Buys 2,000 Shares at $10.30 (NASDAQ: MOBI)

Mobia Medical, Inc. (NASDAQ: MOBI) saw Leavitt Chase C. buy 2,000 shares at $10.30 per share. The buyer is identified with the designation “SEE REMARKS.

Vinay Lochav | 16 September 2026

Neurocrine Biosciences (NASDAQ: NBIX) CCO Reports 67,297 Shares After Forfeiture

NEUROCRINE BIOSCIENCES INC (NASDAQ: NBIX) awarded Chief Commercial Officer Eric Benevich 6,275 shares at $0 on September 11, 2026. A separate transaction on the same date recorded the forfeiture of 3,386 shares at $156.22 per share, with the reported holdings associated with the entries …

Vinay Lochav | 16 September 2026

Parabilis Medicines (NASDAQ: PBLS) Plans Updated Zolucatetide Data Presentation at ESMO

Parabilis Medicines, Inc. (NASDAQ: PBLS) is updating its guidance to reflect an intended oral presentation at the ESMO Congress 2026. The presentation will cover updated clinical data from an ongoing study of zolucatetide in desmoid tumor patients.

Vinay Lochav | 16 September 2026

Patel Naimish: AgomAb Director’s Award Equals About 100.0% of Resulting Holding

AgomAb Therapeutics NV director Patel Naimish was awarded 56,328 derivative securities on 11 September 2026, and his resulting holding was listed at 56,328 derivative securities. The award represents about 100.0% of his resulting derivative-securities position. Naimish is identified as a director of AgomAb Therapeutics …

Vinay Lochav | 16 September 2026

Phio Pharmaceuticals CEO Forfeits 68,550 Shares at $1.03 (NASDAQ: PHIO)

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) Chairman, President and CEO Robert J. Bitterman forfeited 68,550 shares at $1.03 per share on September 11, 2026.

Vinay Lochav | 16 September 2026

CLOVER HEALTH (NASDAQ: CLOV) CEO Retains 2,805,367 Shares After Insider Sale

CLOVER HEALTH INVESTMENTS, CORP. /DE (NASDAQ: CLOV) recorded a sale of 9,273 shares by Jamie L. Reynoso at $4.78 per share. The transaction was dated 15 September 2026. The transaction carries SEC code S. That code denotes an open-market sale.

Vinay Lochav | 16 September 2026

Co-Diagnostics (NASDAQ: CODX) Enters ReadyGo Agreement to Evaluate Co-Dx PCR Compatibility

In August 2026, Co-Diagnostics, Inc. (NASDAQ: CODX) entered into an agreement with ReadyGo Diagnostics Ltd. to evaluate whether ReadyGo’s sample collection and preparation technologies are compatible with its Co-Dx PCR platform.

Vinay Lochav | 16 September 2026

Coya Therapeutics (NASDAQ: COYA) Reaches 100 Patients in ALSTARS Trial

Coya Therapeutics, Inc. (NASDAQ: COYA) has enrolled the 100th patient in its ongoing Phase 2/3 ALSTARS trial evaluating COYA 302 in amyotrophic lateral sclerosis. Based on current enrollment trends, Coya expects to complete enrollment of 120 participants in time to report topline data in …

Vinay Lochav | 16 September 2026

Claritev (NYSE: CTEV) Names Ben Letham Director to Fill Board Vacancy

Claritev Corp (NYSE: CTEV) appointed Ben Letham as a Class I director effective September 14, 2026, adding him to the board’s Risk Committee.

Vinay Lochav | 16 September 2026

CSX (NASDAQ:CSX) Could Offer Nasdaq 100 Investors Clues About the Real Economy

Long before economic data is published, freight is moving, and the railways that carry it offer an early glimpse of how the economy is really doing. CSX (NASDAQ:CSX), one of the largest railroads in the eastern United States, hauls the coal, chemicals, cars and …

Nitish Kishor | 16 September 2026
Support

Hi! How can we help you today?

Loading…